Provided by Tiger Fintech (Singapore) Pte. Ltd.

Esperion Therapeutics

0.8860
+0.00470.53%
Volume:2.90M
Turnover:2.52M
Market Cap:175.29M
PE:-3.21
High:0.8899
Open:0.8800
Low:0.8519
Close:0.8813
Loading ...
May 04, 2021

Major Issues Report

8-K - Current report
Apr 26, 2021

Major Issues Report

8-K - Current report
Feb 23, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 23, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2021

Major Issues Report

8-K - Current report
Jan 06, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 16, 2020

Major Issues Report

8-K - Current report
Dec 15, 2020

Major Issues Report

8-K - Current report
Dec 03, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 16, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Major Issues Report

8-K - Current report